ClinicalTrials.gg
CompletedNCT06653595PAP-LMUpdated Oct 22, 2024

Breastfeeding Support and Promotion Program to Improve the Health of Premature Babies (PAP-LM)

An interventional study of Programme to Support Breastfeeding in Prematurity; Extreme and Prematurity, sponsored by University of Barcelona. Completed at 2 sites in Spain. Open to female participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-10-22.

Sponsored by University of Barcelona · Not applicable, Interventional, and Supportive care

How we know

From the registry’s dates

  • Registered 2 years 7 months after the study started (first participant enrolled Oct 2021, registered Jun 2024).

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
162
Allocation
Randomized
Ages
18 Years and older
Sex
Female
01

Where this study stands

Counted across the records on this site · 2026-11-21

Among 73 studies in Premature Birth with a site in Spain — 16 open to participants now, 17 under way, none of them phase 3. Premature Birth · Spain.

Enrollment
23rd of 56
162 · median 121
Started
2021
with 7 others
No phase
33 of 73
8 open now
Registered
65th of 73
by date

Among the 73 studies in Premature Birth with a site in Spain, this one is the 23rd largest by enrollment of the 56 interventional ones that give a count, is one of 8 that started in 2021, is one of 33 with no phase, and was the 65th registered.

Premature Birth

2,557 studies on the registry are indexed under Premature Birth; 504 are open to participants now.

Browse Premature Birth studies →

Open to participants now

16 of the 73 studies in Premature Birth with a site in Spain are open now. Recruiting first, the newest first:

11 more — sign in →

All 16 open studies →

A study can be open while its sites in Spain have not opened yet or have stopped. Only those recruiting at a site in Spain →

Who these studies take

Of the 318 Premature Birth studies recruiting now, 88 (28%) set no upper age limit and 226 (71%) stop at 75 or younger; 243 take children under 18; 104 take healthy volunteers.

This study: 18 Years and older · female · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 73 studies in Premature Birth with a site in Spain, or all of them as a file.
02

Study summary

This study evaluates the effectiveness of a breastfeeding support and promotion program to increase exclusive breastfeeding rates in the preterm group. The intervention is performed by an Advanced Practice Nurse and International Board Certified Breastfeeding Consultant (IBCLC), with high expertise in breastfeeding problems. It is a combination of face-to-face, home care and telephone attention to improve the adherence to breastfeeding. The intervention lasts 6 months.

Read the detailed description

Will be included moderately premature infants to the Neonatal Unit of the Hospital Clínic who achieve with the inclusion criteria of the study. The sample calculation includes 162 subjects to increase breastfeeding rates to 70% at discharge, 50% at 3 months and 40% at 6 months of the babies. Mothers who wish to exclusively breastfeed up to 6 months and sign the informed consent, will be randomized into the experimental group or control group. The control group will receive usual care and the experimental group will receive 1 pre-discharge face-to-face session, 8 home care sessions up to 4 months and 3 telephone follow-up sessions up to 6 months of baby.

03

Conditions studied

  • Prematurity; Extreme
  • Prematurity

Browse trials for

Keywords

  • IBCLC
  • advance practice nurse
  • best practice
  • breastfeeding rates
  • breastfeeding outcomes
  • interventions
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Moderate premature
  • Late premature babies
  • Admitted to the NICU of Hospital Clínic
  • Single pregnancy
  • Families residing in the Barcelona Metropolitan Area (AMB)
  • Families with a good mental health
  • Families with a desire for Exclusive Breastfeeding up to 6 months

Exclusion criteria

Exclusion Criteria:

  • Maternal diseases that contraindicate breastfeeding
  • Mothers with a history of breast surgery
  • Mothers with a history of severe hypogalactia
  • Premature babies with severe complications
  • Premature babies diagnosed with severe CIR
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
162 participants (actual)

Study arms

  • No intervention
    CONTROL GROUP

    The Control Group receives the usual intervention from the health center, that consists in breastfeeding support in the NICU 1 time/week until hospital discharge.

  • Experimental
    EXPERIMENTAL GROUP

    The Experimental Group receives the PAP-LM programme.

    Other: Programme to Support Breastfeeding

Interventions

  • OtherProgramme to Support Breastfeeding

    The intervention consists of active support for breastfeeding by a lactation expert and IBCLC until the premature baby is 6 months old. The intervention includes: 1 face-to-face pre-discharge session, 8 home sessions up to 4 months and 3 telephone sessions up to 6 months.

06

What researchers measure

Primary outcomes

  1. BREASTFEEDING RATES

    Exclusive Breastfeeding or Parcial Breastfeeding

    Time frame: 15 days postpartum, at 3 months and at 6 months postpartum

Secondary outcomes

  1. PREMATURE GROWTH

    Kilograms, percentiles and Z-scores of weight

    Time frame: 15 days postpartum, at 3 and 6 months postpartum

  2. PREMATURE HEIGHT

    Meters, percentiles and Z-scores of height

    Time frame: 15 days postpartum, at 3 and 6 months postpartum

  3. PREMATURE CRANIAL PERIMETER

    Meters, percentiles and Z-scores of head circumference

    Time frame: 15 days postpartum, at 3 and 6 months postpartum

  4. PUNTUATION IN DEVELOPMENT WITH ASQ-3

    Total puntuation in Ages And Stages Questionnarie of Development (ASQ-3)

    Time frame: At 6 months postpartum

  5. MOTHER EFFICACY WITH BREASTFEEDING (USING BSES)

    The Breastfeeding Self-Efficacy Scale (BSES) is a tool that helps assess how confident a mother feels about her ability to breastfeed. Based on the idea that believing in yourself impacts success, the scale uses 14 questions to measure a mother's sense of capability in different breastfeeding tasks. The higher her score, the more confident she feels. This scale is commonly used by healthcare providers and researchers to better understand where mothers might need extra support, as confidence plays a key role in how long and how successfully they continue breastfeeding.

    Time frame: 15 days postpartum and at 6 months postpartum

07

Study locations

2 sites
  • Rosselló 230
    Barcelona, 08008, Spain
  • C/Sabino de Arana, 1
    Barcelona, 08028, Spain
08

References and documents

Publications

  • Bonuck KA, Trombley M, Freeman K, McKee D. Randomized, controlled trial of a prenatal and postnatal lactation consultant intervention on duration and intensity of breastfeeding up to 12 months. Pediatrics. 2005 Dec;116(6):1413-26. doi: 10.1542/peds.2005-0435. PubMed 16322166 ↗
  • Bonuck K, Stuebe A, Barnett J, Labbok MH, Fletcher J, Bernstein PS. Effect of primary care intervention on breastfeeding duration and intensity. Am J Public Health. 2014 Feb;104 Suppl 1(Suppl 1):S119-27. doi: 10.2105/AJPH.2013.301360. Epub 2013 Dec 19. PubMed 24354834 ↗
  • Dias de Oliveira L, Justo Giugliani ER, Cordova do Espirito Santo L, Meirelles Nunes L. Counselling sessions increased duration of exclusive breastfeeding: a randomized clinical trial with adolescent mothers and grandmothers. Nutr J. 2014 Jul 17;13:73. doi: 10.1186/1475-2891-13-73. PubMed 25033743 ↗
  • Gross RS, Mendelsohn AL, Gross MB, Scheinmann R, Messito MJ. Randomized Controlled Trial of a Primary Care-Based Child Obesity Prevention Intervention on Infant Feeding Practices. J Pediatr. 2016 Jul;174:171-177.e2. doi: 10.1016/j.jpeds.2016.03.060. Epub 2016 Apr 21. PubMed 27113376 ↗
  • Hopkinson J, Konefal Gallagher M. Assignment to a hospital-based breastfeeding clinic and exclusive breastfeeding among immigrant Hispanic mothers: a randomized, controlled trial. J Hum Lact. 2009 Aug;25(3):287-96. doi: 10.1177/0890334409335482. Epub 2009 May 12. PubMed 19436060 ↗
  • Kools EJ, Thijs C, Kester AD, van den Brandt PA, de Vries H. A breast-feeding promotion and support program a randomized trial in The Netherlands. Prev Med. 2005 Jan;40(1):60-70. doi: 10.1016/j.ypmed.2004.05.013. PubMed 15530582 ↗
  • Nabulsi M, Tamim H, Shamsedine L, Charafeddine L, Yehya N, Kabakian-Khasholian T, Masri S, Nasser F, Ayash S, Ghanem D. A multi-component intervention to support breastfeeding in Lebanon: A randomized clinical trial. PLoS One. 2019 Jun 14;14(6):e0218467. doi: 10.1371/journal.pone.0218467. eCollection 2019. PubMed 31199849 ↗
  • O'Reilly SL, McNestry C, McGuinness D, Killeen SL, Mehegan J, Coughlan B, O'Brien EC, O'Brien D, Szafranska M, Brosnan M, Sheehy L, Murtagh R, O'Hagan L, Corbett M, Walsh M, Keogh R, Power P, Woodcock M, Phelan M, Carroll A, Murray S, Scallan C, Dunn E, McAuliffe FM. Multicomponent perinatal breastfeeding support in women with BMI >25: The Latch On multi-centre randomised trial. BJOG. 2024 Aug;131(9):1197-1206. doi: 10.1111/1471-0528.17782. Epub 2024 Feb 12. PubMed 38344894 ↗
  • Petrova A, Ayers C, Stechna S, Gerling JA, Mehta R. Effectiveness of exclusive breastfeeding promotion in low-income mothers: a randomized controlled study. Breastfeed Med. 2009 Jun;4(2):63-9. doi: 10.1089/bfm.2008.0126. PubMed 19239405 ↗
  • Tahir NM, Al-Sadat N. Does telephone lactation counselling improve breastfeeding practices? A randomised controlled trial. Int J Nurs Stud. 2013 Jan;50(1):16-25. doi: 10.1016/j.ijnurstu.2012.09.006. Epub 2012 Oct 17. PubMed 23084438 ↗
  • You H, Lei A, Xiang J, Wang Y, Luo B, Hu J. Effects of breastfeeding education based on the self-efficacy theory on women with gestational diabetes mellitus: A CONSORT-compliant randomized controlled trial. Medicine (Baltimore). 2020 Apr;99(16):e19643. doi: 10.1097/MD.0000000000019643. PubMed 32311936 ↗

Individual participant data

Plan to share: No — The information will be confidential. Participation in the study will be voluntary and optional. Participants may leave the study at any time. No data or results will be transferred to patients.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Oct 2021 to primary completion in Feb 2024, 28 months.

Of 746 non-industry interventional studies with no phase under Premature Birth, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 12 and three quarters within 47. This study's 28 months is above that.

Counting every sponsor, half of 764 studies reached it within 24 months; a quarter within 12 and three quarters within 47.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 5, 2024
First posted
Oct 22, 2024
StartActual
Oct 13, 2021
Primary completionActual
Feb 15, 2024
CompletionActual
Mar 20, 2024
Last update
Oct 22, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Oct 22, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06653595
Responsible party
Mireia Pascual Tutusaus (Principal Investigator, University of Barcelona) — Principal investigator
First posted
Oct 22, 2024
Start date
Oct 13, 2021
Primary completion
Feb 15, 2024
Completion
Mar 20, 2024
Last update
Oct 22, 2024

Study contacts

MIREIA PASCUAL
principal investigator · HOSPITAL CLÍNIC I PROVINICIAL DE BARCELONA

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion